Parameters
- 238 pages
- 9 hours of reading
More about the book
The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher
Book purchase
The Sanford guide to antimicrobial therapy 2015, Various authors
- Language
- Released
- 2015
- product-detail.submit-box.info.binding
- (Paperback)
Payment methods
We’re missing your review here.
- Title
- The Sanford guide to antimicrobial therapy 2015
- Language
- English
- Authors
- Various authors
- Released
- 2015
- Format
- Paperback
- Pages
- 238
- ISBN10
- 1930808844
- ISBN13
- 9781930808843
- Series
- Rating
- 4.45 out of 5
- Description
- The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher